A multicenter randomized trial of personalized acupuncture, fixed acupuncture, letrozole and placebo on live birth for infertility in women with polycystic ovary syndrome

Shiya Huang, Min Hu, Ernest Hung Yu Ng, Elisabet Stener‐Victorin, Yanhua Zheng, Qidan Wen, Cong Wang, Maohua Lai, Juan Li, Xingcheng Gao, Xinhua Wang, Zhenxing Hu, Tian Xia, Rongkui Hu, Jianping Liu, Xiaohui Wen, Shuna Li, Kewei Quan, Xingyan Liang, Hongcai Shang, Hongxia Ma, Jie QiaoResearch Square 2020 · DOI

Abstract

Polycystic Ovary Syndrome (PCOS) is a leading cause of infertility, characterized by hormonal imbalances and ovulatory dysfunction. While letrozole is the current standard for ovulation induction, its impact on live birth rates and pregnancy complications remains a subject of investigation. Acupuncture is a frequently sought alternative, yet clinical trials have often utilized "fixed" protocols that do not account for the individualization central to Traditional Chinese Medicine (TCM). This protocol describes a large-scale, multicenter randomized controlled trial (RCT) designed to evaluate whether personalized acupuncture, based on TCM syndrome differentiation, improves live birth rates compared to fixed acupuncture, letrozole, or placebo.

Introduction

Infertility in women with PCOS is a complex clinical challenge. Letrozole, a selective aromatase inhibitor, is the first-line pharmaceutical intervention for inducing ovulation. However, it does not necessarily address the broader metabolic and hormonal environment that influences miscarriage rates and pregnancy complications.

Traditional Chinese Medicine (TCM) posits that effective treatment requires "syndrome differentiation"—tailoring needle points and techniques to a patient's specific constitution and symptoms. Previous acupuncture trials for PCOS have yielded conflicting results, potentially because they employed standardized, "fixed" protocols for all participants. This study addresses a fundamental question: Does personalizing acupuncture according to TCM principles make it a viable clinical alternative or adjunct to pharmaceutical intervention?

Methods and Study Design

This study is a randomized, assessor-blinded, multicenter trial involving 1,100 women across 28 hospitals in China. Participants are women aged 20–40 diagnosed with PCOS-related infertility.

Intervention Arms

Participants are randomly assigned to one of four groups for a 16-week treatment period:

  1. Personalized Acupuncture: Treatment is tailored to specific TCM syndromes (e.g., Spleen-yang and kidney-yang deficiency). This includes specific needle points, manual manipulation, and moxibustion.
  2. Fixed Acupuncture: A standardized set of acupuncture points is used for all patients, regardless of individual TCM diagnosis.
  3. Letrozole: Participants receive 2.5 mg to 7.5 mg of letrozole daily for five days per cycle.
  4. Placebo Letrozole: An inactive pill serves as the control group.
Figure 1: Study flowchart illustrating the recruitment, randomization, and treatment process for the 1,100 participants across the four study arms.

Hypotheses and Expected Outcomes

The researchers hypothesize a hierarchy of effectiveness for the primary outcome of live birth rate: Letrozole > Personalized Acupuncture > Fixed Acupuncture > Placebo.

Beyond simple ovulation induction, the study aims to determine if personalized acupuncture is superior at "preparing the soil"—improving the metabolic and hormonal environment to reduce pregnancy loss and complications. Secondary outcomes include:

  • Ovulation and conception rates.
  • Changes in hormonal parameters (testosterone, FSH, LH).
  • Metabolic changes and quality-of-life scores (SF-36, PCOS-QOL).

Discussion and Significance

This trial represents the first multicenter RCT to rigorously compare personalized acupuncture against both pharmaceutical standards and fixed-protocol acupuncture. By mapping subjective TCM diagnoses onto repeatable, standardized acupuncture protocols, the study bridges the gap between holistic medicine and clinical rigor. If the results demonstrate that personalized acupuncture significantly outperforms fixed protocols, it will provide a strong evidence base for integrating individualized TCM strategies into modern reproductive medicine.

Summary updated

Abstract

<title>Abstract</title> BACKGROUND traditional Chinese Medicine (TCM) usually involves syndrome and disease differentiation, and for acupuncture selection of appropriate points and skillful needling techniques. Many clinical trials on acupuncture used fixed acupuncture protocols without accounting for individual differences. We here design a multicenter randomized controlled trial (RCT) to evaluate whether personalized or fixed acupuncture increases the likelihood of live births for infertility in women with polycystic ovary syndrome (PCOS) compared with letrozole or placebo letrozole. We hypothesis that letrozole is more effective than personalized acupuncture, and personalized acupuncture is more effective than fixed acupuncture, which is more effective than placebo letrozole. Moreover, personalized acupuncture is more likely to reduce miscarriage rate and the risk of pregnancy complications than letrozole.METHODS / DESIGN The study is a randomized assessor-blind controlled trial. A total of 1,100 infertile women with PCOS will be recruited from 28 hospitals and randomly allocated into four groups: A) personalized acupuncture, B) fixed acupuncture, C) letrozole, or D) placebo letrozole. They will receive treatment for 16 weeks and the primary outcome is live birth. Secondary outcomes include ovulation rate, conception rate, pregnancy rate, pregnancy loss rate, changes in hormonal and metabolic parameters, and changes in quality-of-life scores. The adverse events (AEs) will be recorded throughout the trial. All statistical analyses will be performed using the SPSS program V.21.0 (SPSS, Chicago, Illinois, USA) and a p value &lt;0.05 will be considered statistically significant.DISCUSSION This study is the first multicentre RCT to compare personalized or fixed acupuncture, letrozole or placebo letrozole on live birth for infertility in women with PCOS. The findings will inform whether personalized acupuncture therapy could be as an alternative treatment method on live birth for infertile women with PCOS.
BibTeX
@inproceedings{huang2020multicenter,
  author = {Shiya Huang and Min Hu and Ernest Hung Yu Ng and Elisabet Stener‐Victorin and Yanhua Zheng and Qidan Wen and Cong Wang and Maohua Lai and Juan Li and Xingcheng Gao and Xinhua Wang and Zhenxing Hu and Tian Xia and Rongkui Hu and Jianping Liu and Xiaohui Wen and Shuna Li and Kewei Quan and Xingyan Liang and Hongcai Shang and Hongxia Ma and Jie Qiao},
  title = {{A multicenter randomized trial of personalized acupuncture, fixed acupuncture, letrozole and placebo on live birth for infertility in women with polycystic ovary syndrome}},
  booktitle = {Research Square},
  year = {2020},
  doi = {10.21203/rs.2.14021/v2},
}
Figure